Publisher： Bentham Science Publishers
ISSN： 2212-697X
Source： Clinical Cancer Drugs, Vol.3, Iss.1, 2016-05, pp. : 6-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prostate Cancer Molecular Background: The IGF-1Ec Story
Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. :
Access to resources
Recommend
The IGF Axis in Prostate Cancer
Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. :
Targeting the IGF1 axis in cancer proliferation
By Bruchim Ilan Attias Zohar Werner Haim
Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. :
Background to and Management of Treatment-Related Bone Loss in Prostate Cancer
By Berruti A.
Drugs & Aging, Vol. 19, Iss. 12, 2002-01 ,pp. :
Molecular Therapy Intervention Prospects in Prostate Cancer
Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. :